VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children. (Q51515270)
Jump to navigation
Jump to search
scientific article published on 18 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children. |
scientific article published on 18 October 2011 |
Statements
1 reference
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children. (English)
1 reference
1 reference
Tina T Biss
1 reference
Peter J Avery
1 reference
Leonardo R Brandão
1 reference
Elizabeth A Chalmers
1 reference
Michael D Williams
1 reference
John D Grainger
1 reference
Julian B S Leathart
1 reference
John P Hanley
1 reference
Farhad Kamali
1 reference
18 October 2011
1 reference
1 reference
119
1 reference
3
1 reference
868-873
1 reference
Identifiers
1 reference